Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

Evan Lippman joins Aileron Therapeutics

He has experience at EMD Serono, Pfizer and AstraZeneca

Cubist: Meeting the challenge in antibiotics

Patrick Vink on Cubist Pharmaceuticals’ ambitions in anti-infectives, which have attracted the attention of Merck & Co

23andMe signs Parkinson’s deal with Genentech

Adds to list of pharma tie-ups for genetic testing firm

Digital diagnostic tech improves GP accuracy

New study says using digital diagnostic advice can help reduce risk of misdiagnosis

Daiichi Sankyo logo

Daiichi’s novel anticoagulant Savaysa cleared in US

Approval comes more than three years after it was approved in Japan

- PMLiVE

Gates Foundation sponsors arts campaign to promote vaccination

Social media will play a role in raising awareness for the project

- PMLiVE

Germany gives green light to Viiv’s Triumeq for HIV

But IQWiG recommendation only covers previously untreated adults

- PMLiVE

UCB moves Cimzia into phase III trials for psoriasis

Firm collaborating with Dermira to test efficacy and safety of drug

- PMLiVE

Medelinked app available for Android

Smartphone users can now access and share medical history from their device

- PMLiVE

NHS England names director for new models of care

Samantha Jones recently won NHS chief executive of the year

Novartis building

Novartis files COPD combo in US

QVA149 combines long-acting beta agonist with long-acting muscarinic antagonist

Bristol-Myers Squibb (BMS) building

BMS’ Opdivo set for early access in UK

First anti-PD1 to be given fast-track status in the country

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links